Target Price | $234.09 |
Price | $197.46 |
Potential |
18.55%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target Marsh & McLennan Cos 2026 .
The average Marsh & McLennan Cos target price is $234.09.
This is
18.55%
register free of charge
$270.90
37.19%
register free of charge
$195.05
1.22%
register free of charge
|
|
A rating was issued by 25 analysts: 7 Analysts recommend Marsh & McLennan Cos to buy, 16 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Marsh & McLennan Cos stock has an average upside potential 2026 of
18.55%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 24.46 | 27.28 |
7.57% | 11.52% | |
EBITDA Margin | 28.45% | 28.89% |
2.73% | 1.55% | |
Net Margin | 16.60% | 17.44% |
0.48% | 5.06% |
18 Analysts have issued a sales forecast Marsh & McLennan Cos 2025 . The average Marsh & McLennan Cos sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Marsh & McLennan Cos EBITDA forecast 2025. The average Marsh & McLennan Cos EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Marsh & McLennan Cos Analysts have issued a net profit forecast 2025. The average Marsh & McLennan Cos net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 8.19 | 9.67 |
8.76% | 18.07% | |
P/E | 20.41 | |
EV/Sales | 4.22 |
21 Analysts have issued a Marsh & McLennan Cos forecast for earnings per share. The average Marsh & McLennan Cos EPS is
This results in the following potential growth metrics and future valuations:
Marsh & McLennan Cos...
Analyst | Rating | Action | Date |
---|---|---|---|
Wolfe Research |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 10 2025 |
Analyst Rating | Date |
---|---|
Locked
Wolfe Research:
Locked
➜
Locked
|
Sep 16 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 18 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Aug 13 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jul 21 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Jul 21 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 18 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.